Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial with an open‐label, long‐term extension study

AIMS/INTRODUCTION: To evaluate the efficacy and safety of alogliptin added to treatment with glimepiride. MATERIALS AND METHODS: This multicenter, randomized, double‐blind, parallel‐group, 24‐week (12‐week observation and 12‐week treatment) study compared alogliptin 12.5 or 25 mg in combination with...

Descripción completa

Detalles Bibliográficos
Autores principales: Seino, Yutaka, Hiroi, Shinzo, Hirayama, Masashi, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015431/
https://www.ncbi.nlm.nih.gov/pubmed/24843617
http://dx.doi.org/10.1111/j.2040-1124.2012.00226.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015431/
https://www.ncbi.nlm.nih.gov/pubmed/24843617
http://dx.doi.org/10.1111/j.2040-1124.2012.00226.x

Ejemplares similares